ANGLE plc (ANPCF)
USD 0.16
(0.0%)
USD 0.16
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -18.99 Million GBP | 14.52% |
| 2022 | -21.24 Million GBP | -35.08% |
| 2021 | -15.71 Million GBP | -28.49% |
| 2020 | -12.23 Million GBP | -3.62% |
| 2019 | -11.8 Million GBP | -20.17% |
| 2018 | -9.82 Million GBP | -20.66% |
| 2017 | -8.13 Million GBP | -17.62% |
| 2016 | -6.89 Million GBP | -36.71% |
| 2015 | -5.04 Million GBP | -42.13% |
| 2014 | -3.67 Million GBP | -40.94% |
| 2013 | -2.15 Million GBP | -259.28% |
| 2012 | -703.63 Thousand GBP | 47.96% |
| 2011 | -1.33 Million GBP | -306.01% |
| 2010 | -239 Thousand GBP | 33.67% |
| 2009 | 112 Thousand GBP | 84.82% |
| 2008 | -3.31 Million GBP | 52.16% |
| 2007 | 1.19 Million GBP | -3.86% |
| 2006 | -9.23 Million GBP | -33.32% |
| 2005 | -2.61 Million GBP | 0.0% |
| 2004 | -2.9 Million GBP | -10088.0% |
| 2003 | 2.36 Million GBP | 108.1% |
| 2002 | -297 Thousand GBP | 49.47% |
| 2001 | -926 Thousand GBP | -3.91% |
| 2000 | -1.17 Million GBP | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.89 Million GBP | 8.83% |
| 2024 Q2 | -3.89 Million GBP | 0.0% |
| 2023 Q1 | -5.06 Million GBP | 60.46% |
| 2023 Q3 | -4.26 Million GBP | 56.25% |
| 2023 Q4 | -4.26 Million GBP | 0.0% |
| 2023 FY | - GBP | 14.52% |
| 2023 Q2 | -9.75 Million GBP | -92.54% |
| 2022 Q4 | -12.81 Million GBP | -76.34% |
| 2022 Q2 | -9.38 Million GBP | -90.52% |
| 2022 Q1 | -4.92 Million GBP | 37.03% |
| 2022 FY | - GBP | -35.08% |
| 2022 Q3 | -7.26 Million GBP | 22.51% |
| 2021 Q1 | -4.11 Million GBP | 43.6% |
| 2021 Q4 | -7.81 Million GBP | -104.63% |
| 2021 Q2 | -7.97 Million GBP | -93.69% |
| 2021 FY | - GBP | -28.49% |
| 2021 Q3 | -3.82 Million GBP | 52.09% |
| 2020 Q2 | -5.09 Million GBP | -161.49% |
| 2020 Q1 | -1.94 Million GBP | 0.0% |
| 2020 FY | - GBP | -3.62% |
| 2020 Q3 | -3.93 Million GBP | 22.73% |
| 2020 Q4 | -7.3 Million GBP | -85.63% |
| 2019 Q1 | -2.43 Million GBP | 0.0% |
| 2019 FY | - GBP | -20.17% |
| 2019 Q2 | -2.82 Million GBP | -15.93% |
| 2018 Q3 | -4.42 Million GBP | 0.0% |
| 2018 Q1 | -4.3 Million GBP | -114.65% |
| 2018 Q4 | -2.43 Million GBP | 44.97% |
| 2018 FY | - GBP | -20.66% |
| 2017 Q2 | -1.95 Million GBP | 0.0% |
| 2017 Q4 | -2 Million GBP | -2.69% |
| 2017 Q3 | -1.95 Million GBP | 0.0% |
| 2017 FY | - GBP | -17.62% |
| 2016 Q1 | -1.44 Million GBP | 0.0% |
| 2016 Q3 | -1.39 Million GBP | 0.0% |
| 2016 Q2 | -1.39 Million GBP | 3.12% |
| 2016 FY | - GBP | -36.71% |
| 2015 FY | - GBP | -42.13% |
| 2015 Q1 | -1.06 Million GBP | 0.0% |
| 2015 Q2 | -1.15 Million GBP | -7.9% |
| 2015 Q3 | -1.15 Million GBP | 0.0% |
| 2015 Q4 | -1.44 Million GBP | -24.92% |
| 2014 Q1 | -1.32 Million GBP | -343.24% |
| 2014 Q4 | -1.06 Million GBP | -39.28% |
| 2014 Q3 | -767.5 Thousand GBP | 0.0% |
| 2014 FY | - GBP | -40.94% |
| 2014 Q2 | -767.5 Thousand GBP | 42.18% |
| 2013 Q2 | -263.5 Thousand GBP | -110.8% |
| 2013 Q3 | -263.5 Thousand GBP | 0.0% |
| 2013 FY | - GBP | -259.28% |
| 2013 Q1 | -125 Thousand GBP | 0.0% |
| 2013 Q4 | -299.5 Thousand GBP | -13.66% |
| 2012 Q4 | -125 Thousand GBP | 28.77% |
| 2012 FY | - GBP | 47.96% |
| 2012 Q2 | -175.5 Thousand GBP | 0.0% |
| 2012 Q3 | -175.5 Thousand GBP | 0.0% |
| 2011 FY | - GBP | -306.01% |
| 2010 FY | - GBP | 33.67% |
| 2009 FY | - GBP | 84.82% |
| 2008 FY | - GBP | 52.16% |
| 2007 FY | - GBP | -3.86% |
| 2006 FY | - GBP | -33.32% |
| 2005 FY | - GBP | 0.0% |
| 2004 FY | - GBP | -10088.0% |
| 2003 FY | - GBP | 108.1% |
| 2002 FY | - GBP | 49.47% |
| 2001 FY | - GBP | -3.91% |
| 2000 FY | - GBP | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -1533.62% |
| Arrayit Corporation | -3.07 Million USD | -517.353% |
| Atlantic International Corp. | -5.38 Million USD | -252.515% |
| Biocept, Inc. | -30.24 Million USD | 37.175% |
| Bioqual, Inc. | 3.03 Million USD | 726.566% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -2408.533% |
| DermTech, Inc. | -97.89 Million USD | 80.592% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.652% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 6.143% |
| iMD Companies, Inc. | -154.65 Thousand USD | -12184.445% |
| IDenta Corp. | 71.58 Thousand USD | 26639.735% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 595.152% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 49205.712% |
| InVitro International | 6680.00 USD | 284516.168% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -249.503% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -156476.562% |
| Medical Imaging Corp. | -896.74 Thousand USD | -2018.67% |
| NovelStem International Corp. | -3.78 Million USD | -401.849% |
| Optigenex Inc. | -1.18 Million USD | -1500.962% |
| PharmChem, Inc. | 1.05 Million USD | 1902.887% |
| Proteome Sciences plc | -1.13 Million USD | -1570.976% |
| Response Genetics, Inc | -19.66 Million USD | 3.392% |
| Rennova Health, Inc. | -234.81 Thousand USD | -7991.05% |
| RushNet, Inc. | -614.85 Thousand USD | -2990.012% |
| ScreenPro Security Inc. | -3.43 Million USD | -453.118% |
| Stella Diagnostics Inc. | -5.7 Million USD | -232.882% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | -84.993% |
| Todos Medical Ltd. | -9.39 Million USD | -102.246% |